News

Since Aptuit took over Verona site from GSK in 2010, it had 50 audits and carried out work for more than 90 clients. Aptuit chairman Timothy Tyson said

Forxigatm, available as once-daily tablet, is used in combination with other treatments, if adequate blood glucose control in patients is not provided, with insulin and together with diet

The solution, Patient Document Repository (PDR), provides real-time access to patient documentation in both structured and unstructured formats and ensures that the most up-to-date patient information is available

Operating loss for third quarter of 2012 was $5.53m compared to operating loss $3.43m for the third quarter of 2011. The company reported a net loss of $31.22m,

Max Planck Institute for Molecular Genetics developed the ModCell system and licensed it to Alacris. GSK will provide pre-clinical biology data from oncology research to Alacris, which will

Integrated with the GeneCards, MalaCards, and LifeMap Discovery databases, the new portal provides biomedical researchers access to these databases for identifying stem cell reagents. The new portal also

The sublingual formulation of fentanyl earlier gained approval in US, EU and Canada as cancer pain therapy in patients already taking opioid analgesics. The company confirmed the efficacy

Orphan designation provides NewLink with access to multiple incentives for drug development in EU. Incentives include decreased development costs, right to use to the centralized authorization procedure, 10-year

Previously, Baum served at Pfizer as senior vice president for clinical research, and vice president and head of oncology, where he developed oncology drugs including tyrosine kinase inhibitors